Document is current
Any future updates will be listed below
-
Authors
Narula, Gaurav https://orcid.org/0000-0002-8539-295X
Keerthivasagam, Swaminathan https://orcid.org/0000-0003-2834-3868
Jain, Hasmukh
Punatar, Sachin https://orcid.org/0000-0002-7461-4772
Chichra, Akanksha
Dhamne, Chetan
Tembhare, Prashant https://orcid.org/0000-0002-9030-0415
Subramanian, Papagudi Ganesan https://orcid.org/0000-0001-9107-5937
Patkar, Nikhil https://orcid.org/0000-0001-9234-2857
Poojary, Minal
Gokarn, Anant
Mirgh, Sumeet https://orcid.org/0000-0003-0642-2207
Jindal, Nishant
Nisar, Albeena
Pandit, Deepali
Pandit, Khushali
Dwivedi, Alka
Karulkar, Atharva
Jaiswal, Ankesh Kumar
Khan, Aalia
Shah, Shreshtha
Rafiq, Afrin https://orcid.org/0000-0002-2336-7070
Basu, Moumita
Pendhari, Juber
Asija, Sweety
Chowdury, Ambalika
Banik, Ankit
Moulik, Nirmalya Roy
Srinivasan, Shyam
Bhosle, Shilpushp
Hiregoudar, Sumathi
Ojha, Shashank
Nayak, Lingaraj
Thorat, Jayshree
Bagal, Bhausaheb https://orcid.org/0000-0001-9754-0182
Sengar, Manju https://orcid.org/0000-0002-3509-5682
Khattry, Navin https://orcid.org/0000-0001-5708-6472
Banavali, Shripad
Highfill, Steven
Shah, Nirali N. https://orcid.org/0000-0002-8474-9080
Purwar, Rahul https://orcid.org/0000-0003-3319-0309
- License Information
-
More Information
Article History
Received: 17 December 2024
Revised: 24 March 2025
Accepted: 2 April 2025
First Online: 24 April 2025
Competing interests
: GN serves as a scientific advisor/board member in ImmunoACT. HJ has received research and/or clinical trial support from ImmunoACT, Zydus, and Intas Pharmaceuticals. RP, AK, SS, and AF are equity holders in a private company, have memberships on the entity’s Board of Directors or advisory committees, hold patents and royalties with ImmunoACT, and are currently employed there. JT serves as a consultant for ImmunoACT. NNS is a consultant and/or advisory board member for ImmunoACT, VOR, Cargo, and Lentigen. The remaining authors declare no conflict of interest.
: The prospective study was approved by the institutional review boards and ethical committee clearance was obtained (ECR/149/Inst/MH/2023 and IITB-IEC/2018/023).
: Informed consent was obtained from the caretakers of the patients in our study.
